Loading insider details...
Beta
Latest Form 4 (Jun 9, 2026): Grant/Award of 13,000 CRSP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Aug 8, 2025 | CRISPR Therapeutics AG (CRSP) | Purchase | 20,000 | $1.14M |
| Jun 6, 2025 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Oct 3, 2024 | Inozyme Pharma, Inc. (INZY) | Grant/Award | 1,710 | $7.6K |
| May 31, 2024 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Apr 3, 2024 | Inozyme Pharma, Inc. (INZY) | Exercise/Conversion | 25,000 | n/a |
| Mar 15, 2024 | Inozyme Pharma, Inc. (INZY) | Grant/Award | 300,000 | n/a |
| Jun 9, 2023 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Jun 10, 2022 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 12,000 | n/a |
| Jun 14, 2021 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 10,000 | n/a |